Ranjit Kumar Harwansh (Ranjit K Harwansh)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Radical Prostatectomy

Roux En Y Gastric Bypass

Top Venues

Current pharmaceutical design

Current pharmaceutical biotechnology

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Ranjit Kumar Harwansh, Sonia Chauhan, Dr Rohitas Deshmukh, Rupa Mazumder
Recent Insight into Herbal Bioactives-based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy. Current pharmaceutical biotechnology 25 (14) (2024)
Ranjit Kumar Harwansh, Hemant Bhati, Dr Rohitas Deshmukh
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis. Current pharmaceutical design 30 (6) (2024)
Ranjit Kumar Harwansh, Hemant Bhati, Dr Rohitas Deshmukh
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis. Current pharmaceutical design (2024)
Rutvi Agrawal, Priyanka Jurel, Dr Rohitas Deshmukh, Ranjit Kumar Harwansh, Akash Garg, Ashwini Kumar, Sudarshan Singh, Ajay Guru, Arun Kumar, Vinoth Kumarasamy
Emerging Trends in the Treatment of Skin Disorders by Herbal Drugs: Traditional and Nanotechnological Approach. Pharmaceutics 16 (7) (2024)
Dr Rohitas Deshmukh, Vaibhav Singh, Ranjit Kumar Harwansh, Rutvi Agrawal, Akash Garg, Sudarshan Singh, Gehan M Elossaily, Mohd Nazam Ansari, Nemat Ali, Bhupendra Gopalbhai Prajapati
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications. Pharmaceutics 16 (3) (2024)
Ranjit Kumar Harwansh, Sonia Chauhan, Dr Rohitas Deshmukh, Rupa Mazumder
Recent Insight into Herbal Bioactives-Based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy. Current pharmaceutical biotechnology (2024)
Rutvi Agrawal, Priyanka Jurel, Dr Rohitas Deshmukh, Ranjit Kumar Harwansh, Akash Garg, Ashwini Kumar, Sudarshan Singh, Ajay Guru, Arun Kumar, Vinoth Kumarasamy
Emerging Trends in the Treatment of Skin Disorders by Herbal Drugs: Traditional and Nanotechnological Approach. Pharmaceutics 16 (7) (2024)
Rutvi Agrawal, Priyanka Jurel, Dr Rohitas Deshmukh, Ranjit Kumar Harwansh, Akash Garg, Ashwini Kumar, Sudarshan Singh, Ajay Guru, Arun Kumar, Vinoth Kumarasamy
Emerging Trends in the Treatment of Skin Disorders by Herbal Drugs: Traditional and Nanotechnological Approach. Pharmaceutics 16 (7) (2024)
Ranjit Kumar Harwansh, Hemant Bhati, Dr Rohitas Deshmukh
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis. Current pharmaceutical design 30 (6) (2024)
Dr Rohitas Deshmukh, Vaibhav Singh, Ranjit Kumar Harwansh, Rutvi Agrawal, Akash Garg, Sudarshan Singh, Gehan M Elossaily, Mohd Nazam Ansari, Nemat Ali, Bhupendra Gopalbhai Prajapati
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications. Pharmaceutics 16 (3) (2024)
Dr Rohitas Deshmukh, Vaibhav Singh, Ranjit Kumar Harwansh, Rutvi Agrawal, Akash Garg, Sudarshan Singh, Gehan M Elossaily, Mohd Nazam Ansari, Nemat Ali, Bhupendra Gopalbhai Prajapati
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications. Pharmaceutics 16 (3) (2024)
Fahad Saad Alhodieb, Mohammad Akhlaquer Rahman, Muhammad Abul Barkat, Abdulkareem Ali Alanezi, Harshita Abul Barkat, Hazrina Ab Hadi, Ranjit Kumar Harwansh, Vineet Mittal
Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease. Nanomedicine (London, England) (2023)
Ranjit Kumar Harwansh, Paras Yadav, Rohitas Deshmukh
Current Insight into Novel Delivery Approaches of Resveratrol for Improving Therapeutic Efficacy and Bioavailability with its Clinical Updates. Current pharmaceutical design (2023)